发明名称 HETEROCYCLIC COMPOUND AND AGENT
摘要 <p>PROBLEM TO BE SOLVED: To obtain a new heterocyclic compound having a specified nitrogenous cyclic group and low toxicity, capable of manifesting excellent neurodegeneration inhibitory action and intraencephatic migration and useful for the treatment and prevention of neurodegenerative diseases such as Alzheimer's disease or Down's syndrome. SOLUTION: This compound (or a salt thereof) is represented by formula I [Ar<1> and Ar<2> are each a (substituted) aromatic group; Q is a (substituted) chain aliphatic hydrocarbon bivalent group which may be interposed by a bivalent group selected from O, (oxidized) S and a (substituted) imino; X is H, an electron-attracting group or a (substituted) aromatic group; (A) ring is a (substituted) nitrogenous 5 to 7-membered cyclic group such as a group of formula II (R<7a> and R<7b> are each a 1-6C alkyl or the like)], e.g. 3-[5-(1,4-dimethoxy-3- methylnaphthalen-2-yl)-5-(4-hydroxyphenyl)pentyl]-5,5-dimethyl-1,4,2-d ioxazole. When A ring is a group of formula II, the compound of formula I is obtained by condensation reaction of a compound of formula III with a compound of formula IV (T is a OH protective group) to obtain a compound of formula V and then cyclization reaction of the resultant compound.</p>
申请公布号 JPH11199570(A) 申请公布日期 1999.07.27
申请号 JP19980164557 申请日期 1998.06.12
申请人 TAKEDA CHEM IND LTD 发明人 KATOU KANEYOSHI;TERAUCHI ATSUSHI;TAKAHASHI HIDEKI;NARUO KENICHI
分类号 C07D273/01;A61K31/41;A61K31/42;A61K31/445;A61K31/535;A61P25/00;A61P25/28;A61P43/00;C07D498/10;(IPC1-7):C07D273/01 主分类号 C07D273/01
代理机构 代理人
主权项
地址